StevenHBernsteinMD
Hematology • Rochester, NYProfessor, Medicine, University of Rochester School of Medicine & Dentistry
Are you Dr. Bernstein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 70 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
Box Med
Rochester, NY 14642Phone+1 585-275-0784Fax+1 585-273-5761- Is this information wrong?
Summary
- Dr. Steven Bernstein, MD is a hematologist in Rochester, New York. He is currently licensed to practice medicine in New York. He is affiliated with Highland Hospital and is a Professor at University of Rochester School of Medicine & Dentistry.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1991
University of ChicagoResidency, Internal Medicine, 1984 - 1987
New York University School of MedicineClass of 1984
Certifications & Licensure
NY State Medical License 1985 - 2014
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 22 citationsPhase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma., , , , , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2018 Dec 15
- 11 citationsThe Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies.Katy L. Simonsen, Paula M. Fracasso, Steven H. Bernstein, Megan Wind-Rotolo, Manish Gupta, Adriana Comprelli, Timothy P. Reilly, Cassidy James> ;European Journal of Cancer. 2018 Nov 1
- 81 citationsCirculating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer.Nataly Manjarrez-Orduño, Laurence Menard, Selena Kansal, Paul Fischer, Bijal Kakrecha, Can Jiang, Mark D. Cunningham, Danielle Greenawalt, Vishal Patel, Minghui Yang, ...> ;Frontiers in Immunology. 2018 Aug 3
- Join now to see all
Authored Content
- The Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) Program: Innovative, High-Throughput Clinical Screening of ImmunotherapiesOctober 2018
Hospital Affiliations
Highland HospitalRochester, New York
